Cutting Edge Information, Jan 2010, Pages: 324
Gain instant access to the most up-to-date information on the diabetes market. Scour in-depth profiles of brands and diabetes drug makers to target and seize market share, optimize return
John Wiley and Sons Ltd, Aug 2010, Pages: 192
evidence on these interrelationships by the publication of three books, dealing with the comorbidity of depression with diabetes, heart disease and cancer.
Depression is a frequent and serious comorbid
Business Insights, May 2011, Pages: 132
This report provides comprehensive coverage of the diabetes market, incorporating a disease overview and detailed epidemiological analyses of the therapy area. It makes a wide-ranging assessment
Informa Healthcare, Aug 2010, Pages: 178
Diabetic Neurology offers a unique focus on the broad neurological complications of diabetes, bridging the clinical divide between diabetology and neurology with a practitioner-friendly guide
Clinical Publishing, June 2010, Pages: 192
of excellence
- Public health and patient care for diabetes reviewed
- Aids the physician in prescribing for the diabetic patient presenting with challenging conditions
Readership:
- Cardiologists
Frost & Sullivan, June 2009, Pages: 99
This Frost & Sullivan research service titled Global Diabetes Market provides insight into key industry challenges, market drivers and trends. Defining trends are examined along with revenue
John Wiley and Sons Ltd, July 2010, Pages: 248
Over three editions the Handbook of Diabetes has built a reputation as an essential practical manual on the assessment and management of patients with diabetes. Previously written by Gareth Williams
FACT Research, Oct 2010, Pages: 25
This report describes the diabetic market worldwide. It describe the major markets worldwide and key trends in those markets. Global Diabetic Industry
John Wiley and Sons Ltd, July 2010, Pages: 1144
Over three editions the Textbook of Diabetes has built a reputation as a book that is extremely well-organized and easy to navigate, with exceptional illustrations and an excellent blend of clinical
Frost & Sullivan, Sep 2011, Pages: 151
How Far Would it Go: New Classes of Drugs to Emerge by 2014
The research study "European Diabetes Therapeutics Market" aims to thoroughly assess and analyse the diabetes therapeutics
Global Industry Analysts, Inc., Jan 2011, Pages: 437
This report analyzes the worldwide markets for Diabetes Diagnostics in US$ Million by the following Product Segments: Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter
Business Insights, March 2011, Pages: 133
The diabetes devices market was worth $13.9bn in 2010 and with continued innovation and the increasing prevalence of this disease is poised for continued strong growth through to 2016. This report
Bizacumen Inc., Nov 2009, Pages: 195
Diabetes Diagnosis market is driven by a steady increase in the number of people diagnosed with diabetes, both in the developed and developing parts of the world, and increase in intensive
Global Industry Analysts, Inc., June 2010, Pages: 325
This report analyzes the US Market for Diabetic Retinopathy in US$ Million. Annual estimates and forecasts are provided for the period 2011 through 2015. The report profiles 40 companies including
MP Advisors, Aug 2011
Bydureon – A near term growth driver of the class
Novel delivery platforms and fixed dose combination of GLP-1’s + Insulin will drive growth in longer term
This decade of the diabetes therapy
BioPolaris, Feb 2010, Pages: 58
In 2030, three leading countries with diabetes population, India, China and the USA, will have over 150 million people with diabetes. For the USA, researchers from the University of Chicago (USA
GBI Research, Dec 2010, Pages: 153
“Diabetes Market to 2016 - Biguanides and Insulin Analogs to be the Largest Selling Anti-Diabetic Drugs” provides in-depth analysis of unmet needs, drivers and barriers that impact the global
RNCOS E-Services Private Limited, Feb 2011, Pages: 35
Diabetes is the world’s most costly epidemic. It is anticipated that, over 10% of the population in countries such as, the US, Malaysia, and Indonesia will be diabetic by 2020 and there will be over
Cutting Edge Information, March 2009, Pages: 102
How would you rate the effectiveness of your diabetes Medical Science Liaisons? Can you identify areas for improvement? Or would you like you to create a diabetes MSL team? Alarming global
Timely Data Resources, Inc., Sep 2011, Pages: 17
The Diabetes Disease and Therapy Review provides an overview of Type 1 and Type 2 diabetes, with incidence and prevalence numbers for major countries worldwide, information on diagnosis
